321(g)(1), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or function of the body." FDA's letters to the other manufacturers are similar in their complaints about why their products fall under the agency's regulatory oversight and why the companies are not allowed to market them, despite their oft-cited claims that the products, especially the triple agonists, are for research only
It is not a substitute for professional medical advice, diagnosis, or treatment
BPC-157 is cleared from circulation in approximately 15 minutes, yet its tissue repair signals persist for weeks, suggesting a hit-and-run pharmacological mechanism
Delivery typically 13 business days
Vitamin B12 shots may not be suitable for people with a history of: sensitivity to vitamin B12 Lebers disease, which affects the optic nerve kidney problems hypokalemia (low potassium levels) deficiencies in other nutrients, particularly folic acid and iron Vitamin B12 injections typically begin to work straight away
Finally, very few studies have touched upon any negatives associated with the use of BPC 157 (having no known toxicity level), as well as no obvious conflicts in literature-based ideas being seen